Table of Contents

1 Study Coverage

• 1.1 Antibody Production Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Antibody Production Market Size Growth Rate by Product
  • 1.4.2 Polyclonal antibody
  • 1.4.3 Monoclonal antibody
  • 1.4.4 Murine
  • 1.4.5 Chimeric
  • 1.4.6 Humanized
• 1.5 Market by End User
  • 1.5.1 Global Antibody Production Market Size Growth Rate by End User
  • 1.5.2 Pharmaceutical and biotechnology companies
  • 1.5.3 Research laboratories
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Antibody Production Market Size
  • 2.1.1 Global Antibody Production Revenue 2014-2025
  • 2.1.2 Global Antibody Production Sales 2014-2025
• 2.2 Antibody Production Growth Rate by Regions
  • 2.2.1 Global Antibody Production Sales by Regions
  • 2.2.2 Global Antibody Production Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Antibody Production Sales by Manufacturers
  • 3.1.1 Antibody Production Sales by Manufacturers
  • 3.1.2 Antibody Production Sales Market Share by Manufacturers
  • 3.1.3 Global Antibody Production Market Concentration Ratio (CR5 and HHI)
• 3.2 Antibody Production Revenue by Manufacturers
  • 3.2.1 Antibody Production Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antibody Production Revenue Share by Manufacturers (2014-2019)
• 3.3 Antibody Production Price by Manufacturers
• 3.4 Antibody Production Manufacturing Base Distribution, Product Types
  • 3.4.1 Antibody Production Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Antibody Production Product Type
  • 3.4.3 Date of International Manufacturers Enter into Antibody Production Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Antibody Production Sales by Product
• 4.2 Global Antibody Production Revenue by Product
• 4.3 Antibody Production Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Antibody Production Breakdown Data by End User

6 North America

• 6.1 North America Antibody Production by Countries
  • 6.1.1 North America Antibody Production Sales by Countries
  • 6.1.2 North America Antibody Production Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Antibody Production by Product
• 6.3 North America Antibody Production by End User

7 Europe

• 7.1 Europe Antibody Production by Countries
  • 7.1.1 Europe Antibody Production Sales by Countries
  • 7.1.2 Europe Antibody Production Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Antibody Production by Product
• 7.3 Europe Antibody Production by End User

8 Asia Pacific

• 8.1 Asia Pacific Antibody Production by Countries
  • 8.1.1 Asia Pacific Antibody Production Sales by Countries
  • 8.1.2 Asia Pacific Antibody Production Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Antibody Production by Product
• 8.3 Asia Pacific Antibody Production by End User

9 Central & South America

• 9.1 Central & South America Antibody Production by Countries
  • 9.1.1 Central & South America Antibody Production Sales by Countries
  • 9.1.2 Central & South America Antibody Production Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Antibody Production by Product
• 9.3 Central & South America Antibody Production by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Antibody Production by Countries
  • 10.1.1 Middle East and Africa Antibody Production Sales by Countries
  • 10.1.2 Middle East and Africa Antibody Production Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Antibody Production by Product
• 10.3 Middle East and Africa Antibody Production by End User

11 Company Profiles

• 11.1 Thermo Fisher Scientific, Inc.
  • 11.1.1 Thermo Fisher Scientific, Inc. Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Thermo Fisher Scientific, Inc. Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Thermo Fisher Scientific, Inc. Antibody Production Products Offered
  • 11.1.5 Thermo Fisher Scientific, Inc. Recent Development
• 11.2 GE Healthcare
  • 11.2.1 GE Healthcare Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GE Healthcare Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GE Healthcare Antibody Production Products Offered
  • 11.2.5 GE Healthcare Recent Development
• 11.3 Sartorius AG
  • 11.3.1 Sartorius AG Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Sartorius AG Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Sartorius AG Antibody Production Products Offered
  • 11.3.5 Sartorius AG Recent Development
• 11.4 Merck KGaA
  • 11.4.1 Merck KGaA Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Merck KGaA Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Merck KGaA Antibody Production Products Offered
  • 11.4.5 Merck KGaA Recent Development
• 11.5 Eppendorf AG
  • 11.5.1 Eppendorf AG Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Eppendorf AG Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Eppendorf AG Antibody Production Products Offered
  • 11.5.5 Eppendorf AG Recent Development
• 11.6 Cellab GmbH
  • 11.6.1 Cellab GmbH Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Cellab GmbH Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Cellab GmbH Antibody Production Products Offered
  • 11.6.5 Cellab GmbH Recent Development
• 11.7 Pall Corp.
  • 11.7.1 Pall Corp. Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Pall Corp. Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Pall Corp. Antibody Production Products Offered
  • 11.7.5 Pall Corp. Recent Development
• 11.8 INTEGRA Biosciences AG
  • 11.8.1 INTEGRA Biosciences AG Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 INTEGRA Biosciences AG Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 INTEGRA Biosciences AG Antibody Production Products Offered
  • 11.8.5 INTEGRA Biosciences AG Recent Development
• 11.9 FiberCell Systems Inc.
  • 11.9.1 FiberCell Systems Inc. Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 FiberCell Systems Inc. Antibody Production Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 FiberCell Systems Inc. Antibody Production Products Offered
  • 11.9.5 FiberCell Systems Inc. Recent Development

12 Future Forecast

• 12.1 Antibody Production Market Forecast by Regions
  • 12.1.1 Global Antibody Production Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Antibody Production Revenue Forecast by Regions 2019-2025
• 12.2 Antibody Production Market Forecast by Product
  • 12.2.1 Global Antibody Production Sales Forecast by Product 2019-2025
  • 12.2.2 Global Antibody Production Revenue Forecast by Product 2019-2025
• 12.3 Antibody Production Market Forecast by End User
• 12.4 North America Antibody Production Forecast
• 12.5 Europe Antibody Production Forecast
• 12.6 Asia Pacific Antibody Production Forecast
• 12.7 Central & South America Antibody Production Forecast
• 12.8 Middle East and Africa Antibody Production Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Antibody Production Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Antibody Production market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibody Production market based on company, product type, end user and key regions.

This report studies the global market size of Antibody Production in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Production in these regions.
This research report categorizes the global Antibody Production market by top players/brands, region, type and end user. This report also studies the global Antibody Production market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher Scientific, Inc.
GE Healthcare
Sartorius AG
Merck KGaA
Eppendorf AG
Cellab GmbH
Pall Corp.
INTEGRA Biosciences AG
FiberCell Systems Inc.

Market size by Product
Polyclonal antibody
Monoclonal antibody
Murine
Chimeric
Humanized
Market size by End User
Pharmaceutical and biotechnology companies
Research laboratories
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Antibody Production market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antibody Production market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antibody Production companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antibody Production submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antibody Production are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibody Production market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.